-

Short History of C-L Psychiatry Fellowship at Iowa
I read a short article, “The case for pursuing a consultation-liaison psychiatry fellowship” by Samuel P. Greenstein, MD in Current Psychiatry (Vol. 1, No. 5, May 2022). After 3 years as an attending, he found his calling as a C-L psychiatrist, especially after getting teaching awards from trainees. But when he applied to academic institutions…
-

Iowa City Nature Challenge Begins!
The Iowa City Nature Challenge began on April 29, 2022. It’s sponsored by the University of Iowa Office of Sustainability and the Environment. According to their web site: “From April 29th to May 2nd, find and photograph plants and animals in your backyard, in parks, along city streets, on school grounds—anywhere you find nature in…
-

Not Ambivalent I’m A Hawkeye
I searched the web for a picture of ambivalence and had a tough time finding one. The featured image comes close. The reason I’m ambivalent is because of a conflict I have about the Iowa Hawkeye football program, which is currently the subject of a lawsuit by former African American players compared to the University…
-

Looking Back on Gunslingers and Chess Masters
I was looking at an early version of the handbook of consultation-liaison psychiatry that eventually evolved into what was actually published by Cambridge University Press. I wrote virtually all of the early version and it was mainly for trainees rotating through the consult service. The published book had many talented contributors. I and my department…
-

To Boost or Not to Boost?
To boost or not to boost? That is the question. I’m still thinking about whether or not it’s important for me to get the second booster for the COVID vaccine. What might help me decide is a little bit more information from University of Iowa Hospital epidemiologist Dr. Daniel Diekema, MD. The Omicron subvariant, BA.2,…
-

The Path to Asapiprant: Perspiration or Inspiration?
I just found a University of Iowa Health Care announcement about a potential novel treatment to protect older patients from the ravages of Covid-19 infection. According to the announcement: “An experimental drug that counters immune aging, effectively prevents death in older mice with severe COVID-19, suggesting it may have potential as a therapy to protect…


